Bioprosthetic valve failure of the Inspiris Resilia valve during transcatheter valve implantation. 2023

Yoshikuni Kobayashi, and Kazuaki Okuyama, and Shingo Kuwata, and Masashi Koga, and Masaki Izumo, and Yoshihiro Johnny Akashi
Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-Ku, Kawasaki, 216-8511, Japan. yoshikuni.kobayashi@marianna-u.ac.jp.

UI MeSH Term Description Entries
D011474 Prosthesis Design The plan and delineation of prostheses in general or a specific prosthesis. Design, Prosthesis,Designs, Prosthesis,Prosthesis Designs
D011475 Prosthesis Failure Malfunction of implantation shunts, valves, etc., and prosthesis loosening, migration, and breaking. Prosthesis Loosening,Prosthesis Durability,Prosthesis Migration,Prosthesis Survival,Durabilities, Prosthesis,Durability, Prosthesis,Failure, Prosthesis,Failures, Prosthesis,Loosening, Prosthesis,Loosenings, Prosthesis,Migration, Prosthesis,Migrations, Prosthesis,Prosthesis Durabilities,Prosthesis Failures,Prosthesis Loosenings,Prosthesis Migrations,Prosthesis Survivals,Survival, Prosthesis,Survivals, Prosthesis
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001021 Aortic Valve The valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle. Aortic Valves,Valve, Aortic,Valves, Aortic
D001705 Bioprosthesis Prosthesis, usually heart valve, composed of biological material and whose durability depends upon the stability of the material after pretreatment, rather than regeneration by host cell ingrowth. Durability is achieved 1, mechanically by the interposition of a cloth, usually polytetrafluoroethylene, between the host and the graft, and 2, chemically by stabilization of the tissue by intermolecular linking, usually with glutaraldehyde, after removal of antigenic components, or the use of reconstituted and restructured biopolymers. Glutaraldehyde-Stabilized Grafts,Heterograft Bioprosthesis,Porcine Xenograft Bioprosthesis,Xenograft Bioprosthesis,Bioprostheses,Bioprostheses, Heterograft,Bioprostheses, Porcine Xenograft,Bioprostheses, Xenograft,Bioprosthesis, Heterograft,Bioprosthesis, Porcine Xenograft,Bioprosthesis, Xenograft,Glutaraldehyde Stabilized Grafts,Glutaraldehyde-Stabilized Graft,Graft, Glutaraldehyde-Stabilized,Grafts, Glutaraldehyde-Stabilized,Heterograft Bioprostheses,Porcine Xenograft Bioprostheses,Xenograft Bioprostheses,Xenograft Bioprostheses, Porcine,Xenograft Bioprosthesis, Porcine
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D019918 Heart Valve Prosthesis Implantation Surgical insertion of synthetic material to repair injured or diseased heart valves. Implantation, Heart Valve Prosthesis
D065467 Transcatheter Aortic Valve Replacement Surgical treatment for severe AORTIC VALVE STENOSIS. Transcatheter aortic valve replacement (TAVR) is used as an alternative option in patients who are deemed at high risk or inoperable for traditional open-heart surgery. Transcatheter Aortic Valve Implantation

Related Publications

Yoshikuni Kobayashi, and Kazuaki Okuyama, and Shingo Kuwata, and Masashi Koga, and Masaki Izumo, and Yoshihiro Johnny Akashi
March 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,
Yoshikuni Kobayashi, and Kazuaki Okuyama, and Shingo Kuwata, and Masashi Koga, and Masaki Izumo, and Yoshihiro Johnny Akashi
July 2022, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
Yoshikuni Kobayashi, and Kazuaki Okuyama, and Shingo Kuwata, and Masashi Koga, and Masaki Izumo, and Yoshihiro Johnny Akashi
October 2014, Texas Heart Institute journal,
Yoshikuni Kobayashi, and Kazuaki Okuyama, and Shingo Kuwata, and Masashi Koga, and Masaki Izumo, and Yoshihiro Johnny Akashi
February 2019, Cardiology in the young,
Yoshikuni Kobayashi, and Kazuaki Okuyama, and Shingo Kuwata, and Masashi Koga, and Masaki Izumo, and Yoshihiro Johnny Akashi
June 2024, The Annals of thoracic surgery,
Yoshikuni Kobayashi, and Kazuaki Okuyama, and Shingo Kuwata, and Masashi Koga, and Masaki Izumo, and Yoshihiro Johnny Akashi
November 2019, Interventional cardiology (London, England),
Yoshikuni Kobayashi, and Kazuaki Okuyama, and Shingo Kuwata, and Masashi Koga, and Masaki Izumo, and Yoshihiro Johnny Akashi
September 2023, The Annals of thoracic surgery,
Yoshikuni Kobayashi, and Kazuaki Okuyama, and Shingo Kuwata, and Masashi Koga, and Masaki Izumo, and Yoshihiro Johnny Akashi
April 2020, Kardiologia polska,
Yoshikuni Kobayashi, and Kazuaki Okuyama, and Shingo Kuwata, and Masashi Koga, and Masaki Izumo, and Yoshihiro Johnny Akashi
November 2022, Structural heart : the journal of the Heart Team,
Yoshikuni Kobayashi, and Kazuaki Okuyama, and Shingo Kuwata, and Masashi Koga, and Masaki Izumo, and Yoshihiro Johnny Akashi
September 2023, AsiaIntervention,
Copied contents to your clipboard!